GILDER GAGNON HOWE & CO LLC - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 64 filers reported holding VIRACTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
GILDER GAGNON HOWE & CO LLC ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$255,219
+8.2%
160,515
-0.6%
0.00%0.0%
Q4 2022$235,800
-65.8%
161,507
-0.1%
0.00%
-66.7%
Q3 2022$690,000
+9.4%
161,607
-0.6%
0.01%
+9.1%
Q2 2022$631,000
-27.3%
162,547
-10.9%
0.01%
+37.5%
Q1 2022$868,000
+10.9%
182,396
-15.0%
0.01%
+100.0%
Q4 2021$783,000
-35.5%
214,566
+41.8%
0.00%
-33.3%
Q3 2021$1,214,000
-29.0%
151,350
+0.3%
0.01%
-25.0%
Q2 2021$1,711,000150,8740.01%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 831,625$7,693,0001.42%
BVF INC/IL 3,094,174$28,621,0001.07%
SECTORAL ASSET MANAGEMENT INC 647,556$5,990,0000.45%
Logos Global Management LP 470,000$4,348,0000.42%
AlphaCentric Advisors LLC 92,402$855,0000.29%
SILVERARC CAPITAL MANAGEMENT, LLC 28,570$264,0000.14%
Opaleye Management Inc. 103,600$958,0000.14%
Monashee Investment Management LLC 84,802$784,0000.12%
KETTLE HILL CAPITAL MANAGEMENT, LLC 93,900$869,0000.08%
Ikarian Capital, LLC 155,599$1,439,0000.05%
View complete list of VIRACTA THERAPEUTICS INC shareholders